Literature DB >> 30369710

Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders.

Shadi Nahvi1, Julia H Arnsten2.   

Abstract

Entities:  

Year:  2018        PMID： 30369710      PMCID： PMC6201286          DOI： 10.1016/j.drugalcdep.2018.02.001

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN： 0376-8716            Impact factor:   4.492


× No keyword cloud information.
  45 in total

1.  A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery.

Authors:  Judith J Prochaska; Kevin Delucchi; Sharon M Hall
Journal:  J Consult Clin Psychol       Date:  2004-12

2.  Current Cigarette Smoking Among Adults - United States, 2005-2015.

Authors:  Ahmed Jamal; Brian A King; Linda J Neff; Jennifer Whitmill; Stephen D Babb; Corinne M Graffunder
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-11-11       Impact factor: 17.586

3.  Long-term nicotine replacement therapy: a randomized clinical trial.

Authors:  Robert A Schnoll; Patricia M Goelz; Anna Veluz-Wilkins; Sonja Blazekovic; Lindsay Powers; Frank T Leone; Peter Gariti; E Paul Wileyto; Brian Hitsman
Journal:  JAMA Intern Med       Date:  2015-04       Impact factor: 21.873

4.  Cigarette Smoking Is Associated With Increased Risk of Substance Use Disorder Relapse: A Nationally Representative, Prospective Longitudinal Investigation.

Authors:  Andrea H Weinberger; Jonathan Platt; Hannah Esan; Sandro Galea; Debra Erlich; Renee D Goodwin
Journal:  J Clin Psychiatry       Date:  2017-02       Impact factor: 4.384

5.  The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study.

Authors:  James Poling; Bruce Rounsaville; Kishorchandra Gonsai; Kevin Severino; Mehmet Sofuoglu
Journal:  Am J Addict       Date:  2010 Sep-Oct

6.  Smoking Behaviors and Attitudes Among Clients and Staff at New York Addiction Treatment Programs Following a Smoking Ban: Findings After 5 Years.

Authors:  Anna Pagano; Joseph Guydish; Thao Le; Barbara Tajima; Emma Passalacqua; Arturo Soto-Nevarez; Lawrence S Brown; Kevin L Delucchi
Journal:  Nicotine Tob Res       Date:  2015-05-25       Impact factor: 4.244

7.  Organizational factors as predictors of tobacco cessation pharmacotherapy adoption in addiction treatment programs.

Authors:  Jessica L Muilenburg; Tanja C Laschober; Lillian T Eby
Journal:  J Addict Med       Date:  2014 Jan-Feb       Impact factor: 3.702

8.  Sustained, new, never, and discontinued tobacco cessation services adopters.

Authors:  Lillian T Eby; Tanja C Laschober; Jessica L Muilenburg
Journal:  J Subst Abuse Treat       Date:  2014-08-07

9.  Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort.

Authors:  R D Hurt; K P Offord; I T Croghan; L Gomez-Dahl; T E Kottke; R M Morse; L J Melton
Journal:  JAMA       Date:  1996-04-10       Impact factor: 56.272

10.  Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

Authors:  Robert M Anthenelli; Neal L Benowitz; Robert West; Lisa St Aubin; Thomas McRae; David Lawrence; John Ascher; Cristina Russ; Alok Krishen; A Eden Evins
Journal:  Lancet       Date:  2016-04-22       Impact factor: 79.321
View more
  1 in total

Review 1.  Achieving Smoking Cessation Among Persons with Opioid Use Disorder.

Authors:  Cynthia Vlad; Julia H Arnsten; Shadi Nahvi
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.